Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-25 · accession 0001628280-22-030946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-29 | 2022-11-25 | CRDF | Erlander Mark | CEO, Dir | P - Purchase | $1.43 | +10.0K | 24.5K | +69% | +$14.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-25 | P | A | 10,000 | $1.43 | 24,481 | D | — | — |